Palisade Bio (PALI) EPS (Basic) (QoQ) (2010 - 2026)
Palisade Bio (PALI) EPS (Basic) (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.42% |
| Dec 31, 2025 | 53.25% |
| Sep 30, 2025 | 33.88% |
| Jun 30, 2025 | -24.80% |
| Mar 31, 2025 | 80.55% |
| Dec 31, 2024 | -2.89% |
| Sep 30, 2024 | 30.03% |
| Jun 30, 2024 | 27.67% |
| Mar 31, 2024 | 33.67% |
| Dec 31, 2023 | 10.84% |
| Sep 30, 2023 | 2.08% |
| Jun 30, 2023 | 2.50% |
| Mar 31, 2023 | 87.61% |
| Dec 31, 2022 | 5.19% |
| Sep 30, 2022 | 20.10% |
| Jun 30, 2022 | 52.33% |
| Mar 31, 2022 | 64.55% |
| Dec 31, 2021 | -171.91% |
| Sep 30, 2021 | 93.01% |
| Jun 30, 2021 | -175.11% |